Key result
Hypertension treatment in urban Nigeria incurred an average annual cost of N145,086.12 per patient, leading to catastrophic health expenditures for 30.5% of the lowest-income patients.
Why the study?
The study aimed to investigate the direct average cost of treating hypertension and its catastrophic economic effect on sufferers in Nigeria.
Cross-Sectional
Yes
The cost of treating hypertension in urban Nigeria is substantial and causes catastrophic health expenditure for low-income patients, highlighting the need for targeted healthcare financing policies.
Signals high risk of catastrophic spending on hypertension care among poor urban Nigerians; hypothesis-generating for affordability interventions.
The study aimed to investigate the high prevalence and associated costs of treating hypertension, focusing on its direct average cost and its catastrophic effect on sufferers in Nigeria. Utilizing a descriptive survey research design, data were collected through structured questionnaires administered to patients at the University of Abuja Teaching Hospital and National Hospital, Abuja, Nigeria. The data were analyzed using SPSS version 22, with frequency and percentage calculations. Findings revealed that the average annual cost of treating hypertension was N145,086.12 per patient. Additionally, 191 (82%) patients undertook personal health spending, with 30.5% of the lowest-income patients experiencing catastrophic health expenditures. The results indicated that the cost of treating hypertension was significantly high among urban dwellers and catastrophic for the least earners. The study concluded that the average cost of treating hypertension in urban areas of Nigeria is substantial and particularly burdensome for low-income patients. The findings highlight the need for targeted healthcare financing policies and intervention schemes to alleviate the economic burden of hypertension on sufferers. The study's results are pertinent for policymakers, health planners, and administrators. They underscore the necessity for government intervention through healthcare financing policies and the establishment of programs to subsidize the costs of hypertension treatment. Additionally, the study provides valuable insights for researchers and academics, contributing to the existing knowledge on the economic burden of hypertension and informing future healthcare intervention strategies.
No takes yet. Share an insight, caveat, or question.
Abubakar et al. (2020) conducted a cross-sectional in Hypertension. Hypertension treatment costs was evaluated on Average annual cost of treating hypertension and rate of catastrophic health expenditures. Hypertension treatment in urban Nigeria incurred an average annual cost of N145,086.12 per patient, leading to catastrophic health expenditures for 30.5% of the lowest-income patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: